Farzad SHIDFAR, Shima JAZAYERI, Seyedeh Neda MOUSAVI, Mojtaba MALEK, Agha fateme HOSSEINI, and Basmeh KHOSHPEY*
Animal studies have shown antioxidant effects of Royal Jelly (RJ) and its effect on insulin resistance as the most common complication of Type 2 diabetes. This study was conducted to determine the effect of RJ intake on serum total antioxidant capacity, Malondialdehyde and insulin resistance in T2DM.
In this randomized controlled trial, forty-six type 2 diabetic patients, aged 25–65 years, with BMI of 20–30 kg/m2, and HbA1c of 6–8% were included. The patients were randomly assigned to receive 1000 mg of RJ supplement or placebo, 3 times daily for 8 weeks. HOMA-IR, anthropometric measurements, fasting blood glucose, serum insulin, total antioxidant capacity and malondialdehyde level were measured.
In comparison with placebo, HOMA-IR decreased (P=0.015) while serum total antioxidant capacity increased significantly in RJ group (P=0.016). No significant difference was detected for serum insulin and MDA in two groups.
RJ intake may have favorable effects on serum TAC and HOMA-IR in diabetic patients.
* THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS IS NOT INTENDED TO DIAGNOSE, TREAT CURE OR PREVENT ANY DISEASE.